| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/22/2006 | US20060135588 Preventive and/or therapeutic drugs for inflammatory intestinal diseases |
| 06/22/2006 | US20060135583 e.g. 4-[3'-(3''-aminosulfonylpropyl)-4',4'-dimethyl-5'-oxo-2'-thioxo-1'-imidazolidinyl]-2-trifluoromethylbenzonitrile; anti-androgen agent which has a sufficient antagonistic effect and reduced side effect profile |
| 06/22/2006 | US20060135580 One step reaction of compound such as 3,5-dimethyl-isoxazole with butlyllithium and (3,5-di-tert-butyl)-4-hydroxybenzaldehyde, recrystallization/dehydration alcohol in the presence of a base to give (E)-5-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)vinyl]-3-methylisoxazole |
| 06/22/2006 | US20060135578 Five-membered heterocyclic compounds |
| 06/22/2006 | US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid |
| 06/22/2006 | US20060135576 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
| 06/22/2006 | US20060135572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 06/22/2006 | US20060135568 Methods of treating microbial infections in humans and animals |
| 06/22/2006 | US20060135566 E.g., N-[5-(2-Benzoylamino-4-pyridyl)-4-(3,5-dimethylphenyl)-1,3-thiazol-2-yl]acetamide,; the compounds have adenosine A3 receptor antagonistic activity, a p38 MAP kinase inhibitory action, and a TNF- alpha production-inhibitory action |
| 06/22/2006 | US20060135555 Ring fused pyrazole derivatives as CRF antagonists |
| 06/22/2006 | US20060135554 Novel compounds |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | US20060135541 (3-((Quinazolin-4-yl) amino)-1h-pyrazol-1-yl)acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer |
| 06/22/2006 | US20060135534 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/22/2006 | US20060135532 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis |
| 06/22/2006 | US20060135531 Modulators of dopamine neurotransmission |
| 06/22/2006 | US20060135521 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 06/22/2006 | US20060135520 Method of treating peripheral neuropathy |
| 06/22/2006 | US20060135519 5-aryltetrazole compounds and compositions thereof |
| 06/22/2006 | US20060135513 Methods of treating tumors |
| 06/22/2006 | US20060135508 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/22/2006 | US20060135502 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/22/2006 | US20060135487 Piperazine derivatives and their use as anti-inflammatory agents |
| 06/22/2006 | US20060135449 A NF- kappa B decoy oligodeoxynucleotide of the sequence GGATTTCCC delivered in a liposome through the carotid artery; antiischemic agents, antitumor agents; analgesics, Alzheimer's Disease; gene transfection |
| 06/22/2006 | US20060135445 Breast cancer-resistant protein inhibitor |
| 06/22/2006 | US20060134791 Masked targeted expression cassette which expresses a gene product only in the presence of target molecule; neoplasm |
| 06/22/2006 | US20060134782 Differentiated cells suitable for human therapy |
| 06/22/2006 | US20060134767 Mitotic kinesin binding site |
| 06/22/2006 | US20060134286 Gallocatechin gallate-containing composition |
| 06/22/2006 | US20060134228 Medicine for prevention of and treatment for amyloidosis |
| 06/22/2006 | US20060134208 Controlled release and taste masking oral pharmaceutical composition |
| 06/22/2006 | US20060134205 Process for preparing a pharmaceutical composition |
| 06/22/2006 | US20060134182 Sphingolipids for improvement of the composition of the intestinal flora |
| 06/22/2006 | US20060134167 Administering to the cardiac tissue an angiogenic thrombin derivative peptide and/or inhibiting vascular occulsion or restenosis and stimulating revascularization |
| 06/22/2006 | US20060134119 Drugs containing galectin 9 |
| 06/22/2006 | US20060134117 Preventives/remedies for cancer |
| 06/22/2006 | US20060134115 Method of screening for sensitivity to kinase inhibitor therapy |
| 06/22/2006 | US20060134090 Method and dietary composition for improving lipid digestibility |
| 06/22/2006 | US20060134063 Agents for proliferating pancreatic beta-cells of the islets of langerhans, agents for suppressing apoptosis of said cells, and screening of candidate compounds for these agents |
| 06/22/2006 | US20060133994 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 06/22/2006 | CA2591416A1 Medicinal composition containing fbpase inhibitor |
| 06/22/2006 | CA2591399A1 Aminocarboxylic acid derivative and medicinal use thereof |
| 06/22/2006 | CA2590024A1 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome |
| 06/22/2006 | CA2585560A1 Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 06/21/2006 | EP1672368A1 Diagnostic and therapeutic epitope and transgenic plant |
| 06/21/2006 | EP1672062A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis |
| 06/21/2006 | EP1671973A2 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP1671965A2 Oxacarbocyclic oligomers of fumaric acid |
| 06/21/2006 | EP1671963A1 Endurance improving agent |
| 06/21/2006 | EP1671962A1 Novel fused heterocyclic compound and use thereof |
| 06/21/2006 | EP1671961A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671957A1 Thiadiazoline derivatives |
| 06/21/2006 | EP1671950A1 Cinnamoyl derivatives and use thereof |
| 06/21/2006 | EP1671948A1 Cinnamoyl compound and use of the same |
| 06/21/2006 | EP1671943A1 Preparation of EKB-569 and related intermediates |
| 06/21/2006 | EP1671654A2 Conjugates of hydroxyalkyl starch and an active agent |
| 06/21/2006 | EP1671651A1 Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists |
| 06/21/2006 | EP1671650A1 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
| 06/21/2006 | EP1671637A2 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 06/21/2006 | EP1671632A1 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors |
| 06/21/2006 | EP1671629A1 Human beta-defensin secretion promoter |
| 06/21/2006 | EP1671628A1 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
| 06/21/2006 | EP1671541A1 Disinfectant |
| 06/21/2006 | EP1670762A1 Pyridylacetylenes for use as radiotracers and imaging agents |
| 06/21/2006 | EP1670472A1 Aerosol formulation for inhalation, containing an anticholinergic agent |
| 06/21/2006 | EP1670444A2 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases |
| 06/21/2006 | EP1482968B1 Treatment of type i diabetes mellitus using growth hormone antagonist |
| 06/21/2006 | EP1463504B1 Compositions comprising epothilones and their use for the treatment of the carcinoid syndrome |
| 06/21/2006 | EP1450797B1 Benzothiazole derivatives |
| 06/21/2006 | EP1450781B1 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 06/21/2006 | EP1438316B1 Phosphonic acid compounds as inhibitors of serine proteases |
| 06/21/2006 | EP1423147B1 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 06/21/2006 | EP1420646B1 Antimicrobial agent |
| 06/21/2006 | EP1401415B1 Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases |
| 06/21/2006 | EP1383508B1 Doxycycline for the treatment of acne |
| 06/21/2006 | EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives |
| 06/21/2006 | EP1365766B1 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 06/21/2006 | EP1341779B1 Heterocyclic sulfonamide inhibitors of beta amyloid production |
| 06/21/2006 | EP1303306B1 Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure |
| 06/21/2006 | EP1282599B1 Disulfide derivatives useful for treating allergic diseases |
| 06/21/2006 | EP1276476B1 Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations |
| 06/21/2006 | EP1268419B1 Pyrrolidine derivatives useful as bax inhibitors |
| 06/21/2006 | EP1267866B1 The treatment of respiratory diseases |
| 06/21/2006 | EP1250321B1 Glyburide composition |
| 06/21/2006 | EP1244647B1 Quinazoline derivatives as vegf inhibitors |
| 06/21/2006 | EP1227810B1 Treating cancer by increasing intracellular malonyl coa levels |
| 06/21/2006 | EP1200094B1 Ophthalmic compositions containing antibiotics and nsaids |
| 06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | EP1044186B9 Substituted 2-benzylamino-2-phenyl-acetamide compounds |
| 06/21/2006 | EP1025106B1 Allosteric adenosine receptor modulators |
| 06/21/2006 | EP0981309B1 Differential treatment of prosthetic devices |
| 06/21/2006 | EP0939639B1 Methods and compositions for reducing or eliminating post-surgical adhesion formation |
| 06/21/2006 | EP0912198B1 Immunoliposomes that optimize internalization into target cells |
| 06/21/2006 | EP0909564B1 Erythropoietin solution preparation stabilized with amino acids |
| 06/21/2006 | EP0754044B1 Novel iron chelator and inhibitor of iron-mediated oxidation |
| 06/21/2006 | CN1791594A 2-aminoquinoline derivative |
| 06/21/2006 | CN1791575A Cyanofluoropyrrolidine derivative. |
| 06/21/2006 | CN1791568A Hsp90 family protein inhibitors |
| 06/21/2006 | CN1791428A Preventives/remedies for snore or respiratory disturbances during sleep |